Form 4: Nutanix CFO Sells Shares Under 10b5-1 Plan
SEC Form 4
Nutanix CFO Rukmini Sivaraman sold shares of Class A Common Stock on September 16, 2025, under a pre-arranged 10b5-1 trading plan.
Summary
- Rukmini Sivaraman, CFO of Nutanix, Inc., executed multiple transactions involving Class A Common Stock on September 15 and 16, 2025.
- On September 15, 2025, Sivaraman exercised Restricted Stock Units (RSUs) converting them into Class A Common Stock.
- The RSU conversions occurred in multiple tranches: 2,589, 4,760, 6,250, 4,765, and 2,978 shares.
- Shares were withheld by Nutanix to cover tax obligations totaling 58,770 shares at $78.21.
- On September 16, 2025, Sivaraman sold 11,391 shares at a weighted average price of $78.3438 under a 10b5-1 trading plan.
Sentiment
Score: 5
Explanation: The filing is neutral, reporting routine stock transactions by an executive.
Positives
- The sales were conducted under a pre-arranged 10b5-1 trading plan, suggesting they were planned well in advance.
- Exercise of stock options indicates confidence in the company's long-term prospects.
Negatives
- The sale of 11,391 shares by the CFO could be interpreted negatively by some investors.
- Withholding of 58,770 shares for tax obligations reduces the CFO's holdings.
Risks
- There are no specific risks mentioned in this filing.
Future Outlook
There is no future outlook information in this filing.
Industry Context
This filing reflects routine transactions by a company executive and is typical for executives of publicly traded companies. The use of a 10b5-1 trading plan is a common practice to avoid accusations of insider trading.
Comparison to Industry Standards
- Executive stock sales are a normal part of compensation for publicly traded companies such as Microsoft, Apple, and Google.
- 10b5-1 trading plans are a standard practice among executives at companies like Oracle and IBM to manage their stock transactions.
Stakeholder Impact
- The stock sale could have a minor negative impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 2021-12-15 | First vesting date of 2,589 RSUs in 16 equal quarterly installments. |
| 2022-09-15 | First vesting date of 4,760 RSUs in 16 equal quarterly installments. |
| 2022-12-15 | First vesting date of 6,250 RSUs in 16 equal quarterly installments. |
| 2023-12-15 | First vesting date of 4,765 RSUs in 16 equal quarterly installments. |
| 2024-10-09 | Date of adoption of Rule 10b5-1 trading plan. |
| 2024-12-15 | First vesting date of 2,978 RSUs in 16 equal quarterly installments. |
| 2025-09-15 | Date of RSU exercises and tax withholding. |
| 2025-09-16 | Date of stock sale under 10b5-1 plan. |
| 2025-09-17 | Date of signature on the Form 4 filing. |
Keywords
Nutanix, Rukmini Sivaraman, CFO, stock sale, Form 4, 10b5-1 plan, Class A Common Stock, Restricted Stock Units, RSU
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.